glp-1 obesity drug news oct 21 2025 Why Non-Responders Need Earlier Anti-Obesity Medication Intervention GlobalRPH A Big Week for GLP-1
Description
doi: 10.1038/jcbfm.2013.217 67 FelgerJCAbeTKaunznerUWGottfried-BlackmoreAGal-TothJMcEwenBSet al
Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity
GLP-1 receptors are expressed in brainstem regions implicated in respiratory rhythmogenesis, and their activation has been shown to stabilize breathing patterns and enhance respiratory drive in preclinical models [35]
Patients should be referred to health coaches, dietitians, physiotherapists, or online weight management programmes for additional support
